[PTGX] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
04-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -0.46%
YoY- -51.47%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 60,000 0 0 0 0 0 859 1582.98%
PBT 27,335 -34,105 -38,460 -33,725 -34,194 -31,232 -41,037 -
Tax -4,242 -827 -3,913 -2,296 -2,909 -1,071 -406 375.89%
NP 27,335 -34,105 -38,460 -31,429 -31,285 -30,161 -40,631 -
Tax Rate 15.52% - - - - - - -
Total Cost 32,665 34,105 38,460 31,429 31,285 30,161 41,490 -14.70%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin 45.56 0.00 0.00 0.00 0.00 0.00 -4,730.03 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS 0.45 -0.58 -0.68 -0.62 -0.64 -0.62 -0.83 -
EPS Diluted 0.44 -0.58 -0.68 -0.62 -0.64 -0.61 -0.83 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.